Quote · The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
20VC: $5BN in Revenue, 7 to 7,000 Employees in 9 Months, 206,000 Tests in a Single Day: The Craziest Story in Startups: Curative with Fred Turner
Where this was said
Will AI Make Companies Smaller? Which Jobs Will Survive?
At 1:03:33 · chapter starts 59:00
Harry asks whether current layoffs are genuine AI-driven restructuring or simply corrections for over-hiring in 2021-22. Fred says it's both, but is clear that structural change is real. At Curative, back office workflows are being automated one by one, and he expects the company to shrink from 650 to around 400 employees in the short term before growing again as the business scales. He draws a sharp distinction between the two categories of work that he believes will remain human: deep technical skills (engineers who architect and oversee agent deployments) and authentic relationships (the broker golf dinners, the hospital-system conversations that require physical presence and trust). Clinical roles — care navigators who stay with members throughout their healthcare journey — will grow linearly with membership but become dramatically more productive as agents handle follow-up tasks at population scale. Fred introduces the concept of the Agent Supervisor as the emerging critical role: as agents do 10x the work, they also generate 10x the exception requests requiring human judgment, and managing that queue effectively is a skill that doesn't yet have a name or a training pipeline. He ends with a provocative vision: current-generation models can already do every back-office task at Curative — the only bottleneck is deployment.
Fred Turner is direct: most back office jobs will be replaced by AI, and Curative itself expects to shrink from 650 to around 400 people in the near term. But he argues these were never good jobs — and that UBI plus new social structures are the right policy response, not denial.
As AI agents 10x throughput, they also 10x the volume of approval exceptions requiring human judgment. Fred Turner calls managing this exceptions queue the emerging bottleneck — and 'Agent Supervisor' the most important new role in tech that nobody has yet.
Getting internal sign-off for an AI agent to legally sign contracts using the CEO's signature took months of convincing. But it works: Gwen opens DocuSign, clicks sign, and the agreement is binding. The bigger barrier to AI adoption isn't capability — it's institutional trust.
At the end of the COVID chapter, Curative paid out a dividend returning 10x invested capital to all investors. Then those same investors kept their equity stakes in the health insurance business. That's why the most recent round was led entirely by insiders.
Before pivoting to health insurance, Curative paid out a dividend from COVID profits that returned 10x capital to investors — who then kept their equity stakes.
Curative's latest funding round of $150 million was raised at a $1.3 billion valuation, making it a unicorn health insurance company.
